MKI67 and metastatic neoplasm: A higher risk of death was associated with male sex (HR: 1.58; p = 0.032), Ki67 > 10% (HR 2.18; p = 0.001), presence of extrahepatic metastatic disease (HR: 1.77; p = 0.013), and therapeutic sequence (Table 4).